Back to "Protective immune responses were maintai..."
Claim
Strong Support
mechanistic
Analysis v3

In mice with lupus and chronic lymphocytic leukemia, blocking TACI maintains antibody responses from vaccines and normal blood cell levels without causing widespread immune suppression.

27
Pro
0
Against

Mechanism

Synthesis from 1 study

How it works

Blocking TACI stops harmful immune cells from surviving and hiding from the body's defenses. This lets the immune system stop attacking itself and clear cancer, while still being able to respond to vaccines and keep blood cell levels normal.

Most probable mechanism

In Simple Terms

Blocking TACI stops abnormal signals that make bad immune cells survive and hide from the body's defenses. This lets the immune system stop attacking itself and clear cancer cells, while still being able to respond to vaccines and maintain healthy blood cell levels.

Causal chain
1

TACI receptor blockade prevents BAFF and APRIL ligands from binding, reducing survival signals to autoreactive and malignant B cells

Verified by multiple studies
which leads to
2

Reduced TACI signaling decreases NF-κB activation in pathogenic B cells, lowering production of immunosuppressive cytokines and checkpoint molecules

Verified by multiple studies
which leads to
3

Lower levels of IL-10, TNF, PD-L1, and PD-L2 reverse suppression of T cells, restoring their ability to respond to antigens

Verified by multiple studies
which leads to
4

Normalized germinal center dynamics and T follicular helper cell activity reduce differentiation of autoreactive plasma cells

Verified by multiple studies
which leads to
5

Decreased autoreactive plasma cells and tumor cell migration eliminate sources of autoantibodies and immunosuppressive microenvironments

Verified by multiple studies
which leads to
6

Preserved B-cell homeostasis and intact T-cell-dependent responses maintain antibody production to vaccines and normal hematological parameters

Verified by multiple studies

Evidence from Studies

Supporting (1)

27

Community contributions welcome

27

Abstract PR-06: Disrupting TACI signaling to restore immune balance: harnessing translational opportunities at the intersection of cancer and autoimmunity

Randomized Controlled Trial
Human & Animal

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Sign up to see full verdict

Source Study

Abstract PR-06: Disrupting TACI signaling to restore immune balance: harnessing translational opportunities at the intersection of cancer and autoimmunity

Score: 27
DOI: 10.1158/2326-6074.cimm25-pr-06

Similar Assertions

Blocking TACI signaling in mice with chronic lymphocytic leukemia reduces tumor size, returns IL-6 and IL-10 cytokine levels to normal, restores T-cell populations, and lowers PD-L1 and PD-L2 expression.

27
0
80%

TACI signaling promotes the survival of B cells and disrupts immune regulation in both chronic lymphocytic leukemia and systemic lupus erythematosus, contributing to disease development in both conditions.

27
0
77%

In mouse models, TACI signaling increases the movement of chronic lymphocytic leukemia cells to the spleen and promotes an immune-suppressing environment that allows the tumor to survive.

27
0
70%